Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (221-230 of 457) with videos related to

Pageof 46
Sort By:
American Journal of Hematology|April 12, 2021
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive casesNaseema Gangat, Paola Guglielmelli, Natasha Szuber, et al.
Haematologica|July 24, 2025
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Samuel J Yates, Julian J Weiss, Abigail Sneider, et al.
Haematologica|June 23, 2022
Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experienceAyalew Tefferi, Naseema Gangat, Mithun Shah, et al.
Blood Cancer Journal|September 22, 2023
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneityTalha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, et al.
Mayo Clinic Proceedings|November 8, 2015
Primary Myelodysplastic Syndromes: The Mayo Clinic Experience With 1000 PatientsNaseema Gangat, Mrinal M Patnaik, Kebede Begna, et al.
Blood Cancer Journal|July 8, 2022
Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasmsMithun Vinod Shah, Abhishek A Mangaonkar, Kebede H Begna, et al.
Blood|April 13, 2006
Lenalidomide therapy in myelofibrosis with myeloid metaplasiaAyalew Tefferi, Jorge Cortes, Srdan Verstovsek, et al.
Cancer Discovery|October 29, 2021
Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic LeukemiaMarissa Rashkovan, Robert Albero, Francesca Gianni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemiaScott H Kaufmann, Judith E Karp, Louis Letendre, et al.
Blood Advances|October 13, 2021
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasmsHassan B Alkhateeb, Ahmad Nanaa, David Viswanatha, et al.
Pageof 46

Showing results (221-230 of 457) with videos related to

Sort By:
Pageof 46
American Journal of Hematology|April 12, 2021
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive casesNaseema Gangat, Paola Guglielmelli, Natasha Szuber, et al.
Haematologica|July 24, 2025
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Samuel J Yates, Julian J Weiss, Abigail Sneider, et al.
Haematologica|June 23, 2022
Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experienceAyalew Tefferi, Naseema Gangat, Mithun Shah, et al.
Blood Cancer Journal|September 22, 2023
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneityTalha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, et al.
Mayo Clinic Proceedings|November 8, 2015
Primary Myelodysplastic Syndromes: The Mayo Clinic Experience With 1000 PatientsNaseema Gangat, Mrinal M Patnaik, Kebede Begna, et al.
Blood Cancer Journal|July 8, 2022
Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasmsMithun Vinod Shah, Abhishek A Mangaonkar, Kebede H Begna, et al.
Blood|April 13, 2006
Lenalidomide therapy in myelofibrosis with myeloid metaplasiaAyalew Tefferi, Jorge Cortes, Srdan Verstovsek, et al.
Cancer Discovery|October 29, 2021
Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic LeukemiaMarissa Rashkovan, Robert Albero, Francesca Gianni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemiaScott H Kaufmann, Judith E Karp, Louis Letendre, et al.
Blood Advances|October 13, 2021
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasmsHassan B Alkhateeb, Ahmad Nanaa, David Viswanatha, et al.
Pageof 46